Covid19 : Covaxin is now a universal vaccine for adults and children
Hyderabad-based company Bharat Biotech on Thursday said that it’s Covid19 vaccine Covaxin is now a universal vaccine for adults and children. The firm has said that it’s goal of developing a global vaccine against Covid19 have been achieved.
Bharat Biotech has also said that Covaxin can neutralise both Delta and Omicron variants of Covid19. It also mentioned that earlier studies demonstrated the neutralising potential of Covaxin against SARS-CoV-2 Variants of Concern Alpha, Beta, Delta, Zeta and Kappa.
In the study, conducted by the Emory Vaccine Centre using a live virus neutralisation assay, 100% of the test serum samples showed neutralisation of the Delta variant and over 90% of serum samples showed neutralisation of Omicron Bharat Biotech said on Wednesday.
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children alike. Covaxin is a ready-to-use, liquid vaccine, stored at 2 – 8°C, with 12 months shelf life and multi-dose vial policy. The same doses of vaccine can also be used for two-dose primary immunisation in adults and children and for booster dose vaccinations, making it truly a universal vaccine. Covaxin is not currently authorised or approved for use as a primary or booster dose in the United States.